◆Jinain Pharmaceutical = Recorded an evaluation loss on derivative financial liabilities worth 5.4 billion KRW
◆Gwanglim = Recorded an evaluation loss on derivative liabilities worth 35.3 billion KRW
◆Sangji Kailum = CEO Choi Ki-bo's term expired... Kim Young-shin appointed as new CEO
◆Samkang M&T = Signed a contract with the Public Procurement Service to build and supply two 3,000-ton patrol vessels worth 138.9 billion KRW
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
